Retraction: miR-506 functions as a tumor suppressor in glioma by targeting STAT3 (Oncology Reports (2016) 35 (1057-1064) DOI: 10.3892/or.2015.4406);MIR-506 functions as a tumor suppressor in glioma by targeting STAT3

Oncology Reports

Volumn 35, Issue 2, 2016, Pages 1057-1064

  Peng, Tao ^a   Zhou, Lixiang ^a   Zuo, Ling ^b   Luan, Yongxin ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Glioma; MIR 506; Proliferation; STAT3

Indexed keywords

CYCLIN D1; GELATINASE A; MICRORNA; MICRORNA 506; PROTEIN BCL 2; STAT3 PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN506 MICRORNA, HUMAN; RNA; STAT3 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; CANCER INHIBITION; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; ADULT; ANIMAL; ANTAGONISTS AND INHIBITORS; ASTROCYTE; BAGG ALBINO MOUSE; BRAIN TUMOR; CELL DIVISION; CELL LINE; CELL MOTION; CYTOLOGY; DRUG SCREENING; GENETIC TRANSFECTION; GENETICS; GERMFREE ANIMAL; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION; TUMOR STEM CELL ASSAY;

3' UNTRANSLATED REGIONS; ADULT; ANIMALS; ASTROCYTES; BRAIN NEOPLASMS; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GLIOMA; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RNA, NEOPLASM; SPECIFIC PATHOGEN-FREE ORGANISMS; STAT3 TRANSCRIPTION FACTOR; TRANSFECTION; TUMOR STEM CELL ASSAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84954288225     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2021.8212     Document Type: Erratum

References (35)

1. Reardon DA, Rich JN, Friedman HS and Bigner DD: Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 24: 1253-1265, 2006.
2. Holland EC: Gliomagenesis: Genetic alterations and mouse models. Nat Rev Genet 2: 120-129, 2001.
3. Clarke J, Butowski N and Chang S: Recent advances in therapy for glioblastoma. Arch Neurol 67: 279-283, 2010.
4. Babu R, Kranz PG, Agarwal V, McLendon RE, Thomas S, Friedman AH, Bigner DD and Adamson C: Malignant brainstem gliomas in adults: Clinicopathological characteristics and prognostic factors. J Neurooncol 119: 177-185, 2014.
5. Grauer OM, Wesseling P and Adema GJ: Immunotherapy of diffuse gliomas: Biological background, current status and future developments. Brain Pathol 19: 674-693, 2009.
6. Fabian MR, Sonenberg N and Filipowicz W: Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379, 2010.
7. Guo H, Ingolia NT, Weissman JS and Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840, 2010.
8. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
9. Almeida MI, Reis RM and Calin GA: MicroRNA history: Discovery, recent applications, and next frontiers. Mutat Res 717: 1-8, 2011.
10. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
11. Farazi TA, Spitzer JI, Morozov P and Tuschl T: miRNAs in human cancer. J Pathol 223: 102-115, 2011.
12. McManus MT: MicroRNAs and cancer. Semin Cancer Biol 13: 253-258, 2003.
13. Calin GA and Croce CM: MicroRNA-cancer connection: The beginning of a new tale. Cancer Res 66: 7390-7394, 2006.
14. Wen SY, Lin Y, Yu YQ, Cao SJ, Zhang R, Yang XM, Li J, Zhang YL, Wang YH, Ma MZ, et al: miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer. Oncogene 34: 717-725, 2015.
15. Yu F, Lv M, Li D, Cai H, Ma L, Luo Q, Yuan X and Lv Z: miR-506 over-expression inhibits proliferation and metastasis of breast cancer cells. Med Sci Monit 21: 1687-1692, 2015.
16. Sun Y, Hu L, Zheng H, Bagnoli M, Guo Y, Rupaimoole R, Rodriguez-Aguayo C, Lopez-Berestein G, Ji P, Chen K, et al: miR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer. J Pathol 235: 25-36, 2015.
17. Deng L and Liu H: MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6. Int J Clin Exp Med 8: 1862-1870, 2015.
18. Sakimura S, Sugimachi K, Kurashige J, Ueda M, Hirata H, Nambara S, Komatsu H, Saito T, Takano Y, Uchi R, et al: The miR-506-induced epithelial-mesenchymal transition is involved in poor prognosis for patients with gastric cancer. Ann Surg Oncol: Feb 24, 2015 (Epub ahead of print). doi:10.1245/s10434-015-4418-2.
19. Karsy M, Arslan E and Moy F: Current progress on understanding microRNAs in glioblastoma multiforme. Genes Cancer 3: 3-15, 2012.
20. Tivnan A and McDonald KL: Current progress for the use of miRNAs in glioblastoma treatment. Mol Neurobiol 48: 757-768, 2013.
21. Liu G, Sun Y, Ji P, Li X, Cogdell D, Yang D, Parker Kerrigan BC, Shmulevich I, Chen K, Sood AK, et al: miR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer. J Pathol 233: 308-318, 2014.
22. Zhao Y, Liu H, Li Y, Wu J, Greenlee AR, Yang C and Jiang Y: The role of miR-506 in transformed 16HBE cells induced by anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide. Toxicol Lett 205: 320-326, 2011.
23. Yang FQ, Zhang HM, Chen SJ, Yan Y and Zheng JH: miR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1. PLoS One 10: e0120258, 2015.
24. Sun Y, Mezzanzanica D and Zhang W: miR-506: A multitasker in suppression of the epithelial-to-mesenchymal transition. RNA Dis 1: e447, 2014.
25. Arora H, Qureshi R and Park WY: miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines. PLoS One 8: e64273, 2013.
26. Tong JL, Zhang CP, Nie F, Xu XT, Zhu MM, Xiao SD and Ran ZH: MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells. FEBS Lett 585: 3560-3568, 2011.
27. Streicher KL, Zhu W, Lehmann KP, Georgantas RW, Morehouse CA, Brohawn P, Carrasco RA, Xiao Z, Tice DA, Higgs BW, et al: A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth. Oncogene 31: 1558-1570, 2012.
28. Siciliano V, Garzilli I, Fracassi C, Criscuolo S, Ventre S and di Bernardo D: MiRNAs confer phenotypic robustness to gene networks by suppressing biological noise. Nat Commun 4: 2364, 2013.
29. Alvarez JV, Mukherjee N, Chakravarti A, Robe P, Zhai G, Chakladar A, Loeffler J, Black P and Frank DA: A STAT3 gene expression signature in gliomas is associated with a poor prognosis. Transl Oncogenomics 2: 99-105, 2007.
30. Turkson J: STAT proteins as novel targets for cancer drug discovery. Expert Opin Ther Targets 8: 409-422, 2004.
31. Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S and Weinstein IB : Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 62: 3351-3355, 2002.
32. Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, et al: Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 22: 319-329, 2003.
33. Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F, Sawaya R and Huang S: Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 23: 3550-3560, 2004.
34. Alas S and Bonavida B: Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res 61: 5137-5144, 2001.
35. Aoki Y, Feldman GM and Tosato G: Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 101: 1535-1542, 2003.